Nantahala Capital Management »

Urogen Pharma shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $14M 1.0M 13.70
2025-03-31 $15M 1.4M 11.06
2024-12-31 $15M 1.4M 10.65

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Edwards Lifesciences Put Option (EW)
Hilton Grand Vacations (HGV)
Establishment Labs Holdings Ord (ESTA)
Peloton Interactive Cl A Com (PTON)
Spdr Series Trust S&p Biotech Put Option (XBI)
Herbalife Com Shs (HLF)
Soleno Therapeutics (SLNO)
Ban (TBBK)
Uniqure Nv SHS (QURE)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Viatris Call Option (VTRS)
Abivax Sa Sponsored Ads (ABVX)
Xtant Med Hldgs Com New (XTNT)
Fulcrum Therapeutics (FULC)

View all positions for Nantahala Capital Management

Top funds holding Urogen Pharma

Rtw Investments
Paradigm Biocapital Advisors
Toronto-Dominion Bank
BlackRock
Leucadia National Corporation
Silverarc Capital Management
Millennium Management
SG Americas Securities
Acorn Capital Advisors
Menora Mivtachim Holdings
Caption Management
Tang Capital Management
D. E. Shaw & Co
State Street Corporation
Citadel Advisors

View all funds holding Urogen Pharma